Efficacy and safety of GH treatment in Japanese pediatric patients with SHOX deficiency: an open-label extension study
{{output}}
We have previously published efficacy and safety data up to 24 mo of GH treatment (0.35 mg/kg/wk) for SHOX-related short stature in 19 Japanese pediatric patients before pubertal entry (jRCT2080223889). Here, we report similar efficacy and safety data up to 48... ...
